| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.32 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |